Deraos S - Search Results

1

Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85.

Tselios T, Daliani I, Deraos S, Thymianou S, Matsoukas E, Troganis A, Gerothanassis I, Mouzaki A, Mavromoustakos T, Probert L, Matsoukas J. Tselios T, et al. Among authors: deraos s. Bioorg Med Chem Lett. 2000 Dec 18;10(24):2713-7. doi: 10.1016/s0960-894x(00)00556-4. Bioorg Med Chem Lett. 2000. PMID: 11133075

2

Conformational studies of immunodominant myelin basic protein 1-11 analogues using NMR and molecular modeling.

Laimou D, Lazoura E, Troganis AN, Matsoukas MT, Deraos SN, Katsara M, Matsoukas J, Apostolopoulos V, Tselios TV. Laimou D, et al. Among authors: deraos sn. J Comput Aided Mol Des. 2011 Nov;25(11):1019-32. doi: 10.1007/s10822-011-9481-6. Epub 2011 Nov 1. J Comput Aided Mol Des. 2011. PMID: 22042377

3

Antagonistic effects of human cyclic MBP(87-99) altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferation.

Tselios T, Apostolopoulos V, Daliani I, Deraos S, Grdadolnik S, Mavromoustakos T, Melachrinou M, Thymianou S, Probert L, Mouzaki A, Matsoukas J. Tselios T, et al. Among authors: deraos s. J Med Chem. 2002 Jan 17;45(2):275-83. doi: 10.1021/jm0102147. J Med Chem. 2002. PMID: 11784132

4

NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations.

Tzakos AG, Fuchs P, van Nuland NA, Troganis A, Tselios T, Deraos S, Matsoukas J, Gerothanassis IP, Bonvin AM. Tzakos AG, et al. Among authors: deraos s. Eur J Biochem. 2004 Aug;271(16):3399-413. doi: 10.1111/j.1432-1033.2004.04274.x. Eur J Biochem. 2004. PMID: 15291817 Free article.

5

Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators.

Matsoukas J, Apostolopoulos V, Kalbacher H, Papini AM, Tselios T, Chatzantoni K, Biagioli T, Lolli F, Deraos S, Papathanassopoulos P, Troganis A, Mantzourani E, Mavromoustakos T, Mouzaki A. Matsoukas J, et al. Among authors: deraos s. J Med Chem. 2005 Mar 10;48(5):1470-80. doi: 10.1021/jm040849g. J Med Chem. 2005. PMID: 15743189

6

Design, synthesis, and molecular modeling of a novel amide-linked cyclic GnRH analogue cyclo(4-9)[Lys4,D-Trp6,Glu9]GnRH: stimulation of gonadotropin gene expression.

Keramida MK, Tselios T, Mantzourani E, Papazisis K, Mavromoustakos T, Klaussen C, Agelis G, Deraos S, Friligou I, Habibi H, Matsoukas J. Keramida MK, et al. Among authors: deraos s. J Med Chem. 2006 Jan 12;49(1):105-10. doi: 10.1021/jm050683z. J Med Chem. 2006. PMID: 16392796

7

Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP(87-99)) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering disease.

Deraos G, Chatzantoni K, Matsoukas MT, Tselios T, Deraos S, Katsara M, Papathanasopoulos P, Vynios D, Apostolopoulos V, Mouzaki A, Matsoukas J. Deraos G, et al. Among authors: deraos s. J Med Chem. 2008 Dec 25;51(24):7834-42. doi: 10.1021/jm800891n. J Med Chem. 2008. PMID: 19053745

8

Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides.

Tselios T, Daliani I, Probert L, Deraos S, Matsoukas E, Roy S, Pires J, Moore G, Matsoukas J. Tselios T, et al. Among authors: deraos s. Bioorg Med Chem. 2000 Aug;8(8):1903-9. doi: 10.1016/s0968-0896(00)00134-6. Bioorg Med Chem. 2000. PMID: 11003134

9

Animal models of central nervous system immune-mediated diseases: therapeutic interventions with bioactive peptides and mimetics.

Grigoriadis N, Tselios T, Deraos S, Orologas A, Deraos G, Matsoukas J, Mavromatis I, Milonas I. Grigoriadis N, et al. Among authors: deraos s. Curr Med Chem. 2005;12(13):1513-9. doi: 10.2174/0929867054038991. Curr Med Chem. 2005. PMID: 15974984 Review.

10

Advances in the treatment of autoimmune diseases; cellular activity, type-1/type-2 cytokine secretion patterns and their modulation by therapeutic peptides.

Mouzaki A, Deraos S, Chatzantoni K. Mouzaki A, et al. Among authors: deraos s. Curr Med Chem. 2005;12(13):1537-50. doi: 10.2174/0929867054039044. Curr Med Chem. 2005. PMID: 15974986 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters